Reducing the glycolysis of tumor endothelial cells by inhibiting the function of PFKFB3 inhibits their proliferation and thus normalizes the tumor vasculature as evidenced by regular TEC alignment, a dense tumor vascular barrier, and unobstructed blood perfusion. This evidence concerns the gene PFKFB3 and neoplasm.